Skip to main content
Premium Trial:

Request an Annual Quote

Mexico To Open National Medical Genomics Center

NEW YORK, Aug. 4, (GenomeWeb News) - The National Institute of Health in Mexico announced last month that a national medical genomics center will be created as part of a nationwide plan that was started four years ago to improve healthcare.


The center, INMEGEN will serve to apply knowledge of the human genome towards improving the health of Mexicans, said Gerardo Jimenez Sanchez, the director of the new center during an announcement ceremony on July 19.


Secretary of Health Julio Frenk also said in a statement that the advent of genomic medicine represents a change in paradigm. "The clinical approach up to now was to diagnose and treat," said Frenk. "The new focus will be to predict and to prevent. Without abandoning our current community actions, genomic medicine allows us to advance to a more individualized medicine based on specific knowledge of the characteristics of the Mexican population."


Other officials present at the ceremony included President Vicente Fox Quesada, Jose Angel Cordova, the president of the Commission of Health and Reyes Tamez Guerra, the secretary of public education.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.